317 related articles for article (PubMed ID: 27427516)
1. Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity.
Miller RC; Murley JS; Rademaker AW; Woloschak GE; Li JJ; Weichselbaum RR; Grdina DJ
Free Radic Biol Med; 2016 Oct; 99():110-119. PubMed ID: 27427516
[TBL] [Abstract][Full Text] [Related]
2. ROS modifiers and NOX4 affect the expression of the survivin-associated radio-adaptive response.
Murley JS; Arbiser JL; Weichselbaum RR; Grdina DJ
Free Radic Biol Med; 2018 Aug; 123():39-52. PubMed ID: 29660403
[TBL] [Abstract][Full Text] [Related]
3. TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive Response.
Murley JS; Miller RC; Weichselbaum RR; Grdina DJ
Radiat Res; 2017 Nov; 188(5):579-590. PubMed ID: 28813624
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of a metformin-mediated radiation response in SA-NH and FSa tumor cells treated under in vitro and in vivo growth conditions.
Murley JS; Miller RC; Senlik RR; Rademaker AW; Grdina DJ
Int J Radiat Biol; 2017 Jul; 93(7):665-675. PubMed ID: 28281393
[TBL] [Abstract][Full Text] [Related]
5. NFκB and Survivin-Mediated Radio-Adaptive Response.
Grdina DJ; Murley JS; Miller RC; Woloschak GE; Li JJ
Radiat Res; 2015 Apr; 183(4):391-7. PubMed ID: 25763931
[TBL] [Abstract][Full Text] [Related]
6. A survivin-associated adaptive response in radiation therapy.
Grdina DJ; Murley JS; Miller RC; Mauceri HJ; Sutton HG; Li JJ; Woloschak GE; Weichselbaum RR
Cancer Res; 2013 Jul; 73(14):4418-28. PubMed ID: 23651635
[TBL] [Abstract][Full Text] [Related]
7. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells.
Lai JM; Chang JT; Wen CL; Hsu SL
Eur J Pharmacol; 2009 Nov; 623(1-3):1-9. PubMed ID: 19744477
[TBL] [Abstract][Full Text] [Related]
8. Emodin potentiates the anticancer effect of cisplatin on gallbladder cancer cells through the generation of reactive oxygen species and the inhibition of survivin expression.
Wang W; Sun Y; Li X; Li H; Chen Y; Tian Y; Yi J; Wang J
Oncol Rep; 2011 Nov; 26(5):1143-8. PubMed ID: 21769433
[TBL] [Abstract][Full Text] [Related]
9. Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein.
Shao Y; Liu Y; Shao C; Hu J; Li X; Li F; Zhang L; Zhao D; Sun L; Zhao X; Kopecko DJ; Kalvakolanu DV; Li Y; Xu DQ
Cancer Gene Ther; 2010 Dec; 17(12):844-54. PubMed ID: 20706288
[TBL] [Abstract][Full Text] [Related]
10. Delayed radioprotection by NFkappaB-mediated induction of Sod2 (MnSOD) in SA-NH tumor cells after exposure to clinically used thiol-containing drugs.
Murley JS; Kataoka Y; Cao D; Li JJ; Oberley LW; Grdina DJ
Radiat Res; 2004 Nov; 162(5):536-46. PubMed ID: 15624308
[TBL] [Abstract][Full Text] [Related]
11. Are hypoxic cells critical for the outcome of fractionated radiotherapy in a slow-growing mouse tumor?
Urano M; Nishimura Y; Kuroda M; Reynolds R
Radiother Oncol; 1998 Aug; 48(2):221-8. PubMed ID: 9783896
[TBL] [Abstract][Full Text] [Related]
12. Modulating Survivin as a Radioresistant Factor, Caspase-3, and Apoptosis by Omega-3 Docosahexaenoic Acid Sensitizes Mutant-p53 Colorectal Cancer Cells to γ-Irradiation.
Hosseini F; Sam MR; Jabbari N; Mozdarani H
Cancer Biother Radiopharm; 2018 Nov; 33(9):387-395. PubMed ID: 30395490
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line.
Kappler M; Taubert H; Bartel F; Blümke K; Panian M; Schmidt H; Dunst J; Bache M
Oncol Rep; 2005 Jan; 13(1):167-72. PubMed ID: 15583820
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of radiation cytotoxicity in murine cancer cells by electroporation: in vitro and in vivo studies.
Shil P; Sanghvi SH; Vidyasagar PB; Mishra KP
J Environ Pathol Toxicol Oncol; 2005; 24(4):291-8. PubMed ID: 16393122
[TBL] [Abstract][Full Text] [Related]
15. The combined effect of survivin-targeted shRNA and emodin on the proliferation and invasion of ovarian cancer cells.
Xue H; Chen Y; Cai X; Zhao L; He A; Guo K; Zheng X
Anticancer Drugs; 2013 Oct; 24(9):937-44. PubMed ID: 23921083
[TBL] [Abstract][Full Text] [Related]
16. Tumor sensitizing effect by misonidazole in a clinically relevant radiation dose range.
Grdina DJ; Thames HD; Milas L
Int J Radiat Oncol Biol Phys; 1984 Mar; 10(3):379-83. PubMed ID: 6706731
[TBL] [Abstract][Full Text] [Related]
17. Heavy ion beams induce survivin expression in human hepatoma SMMC-7721 cells more effectively than X-rays.
Gong L; Jin X; Li Q; Liu J; An L
Acta Biochim Biophys Sin (Shanghai); 2007 Aug; 39(8):575-82. PubMed ID: 17687492
[TBL] [Abstract][Full Text] [Related]
18. Gambogic Acid Inhibits Malignant Melanoma Cell Proliferation Through Mitochondrial p66shc/ROS-p53/Bax-Mediated Apoptosis.
Liang L; Zhang Z
Cell Physiol Biochem; 2016; 38(4):1618-30. PubMed ID: 27119348
[TBL] [Abstract][Full Text] [Related]
19. Expression of manganese superoxide dismutase reduces tumor control radiation dose: gene-radiotherapy.
Urano M; Kuroda M; Reynolds R; Oberley TD; St Clair DK
Cancer Res; 1995 Jun; 55(12):2490-3. PubMed ID: 7780953
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
